These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5983913)

  • 1. Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements.
    Hebbard FW; Fischer R
    Psychopharmacologia; 1966; 9(2):146-56. PubMed ID: 5983913
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
    Ley L; Holze F; Arikci D; Becker AM; Straumann I; Klaiber A; Coviello F; Dierbach S; Thomann J; Duthaler U; Luethi D; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psycho-dysleptics].
    Polvan O
    Turk Tip Cemiy Mecm; 1966 Nov; 32(11):661-70. PubMed ID: 5979072
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.
    Schechter MD; Rosecrans JA
    Psychopharmacologia; 1972; 26(3):313-6. PubMed ID: 5073050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Various psychodysleptic substances].
    Bernik V
    Rev Paul Med; 1972 Aug; 80(2):115-7. PubMed ID: 4671580
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of psychotomimetic drugs on primary suggestibility.
    Sjoberg BM; Hollister LE
    Psychopharmacologia; 1965 Nov; 8(4):251-62. PubMed ID: 5885648
    [No Abstract]   [Full Text] [Related]  

  • 7. Hallucinogens and dominance behavior of the rat.
    Uyeno ET
    Proc West Pharmacol Soc; 1967; 10():94. PubMed ID: 6055511
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of isolation-induced attack behavior of mice by drugs.
    Uyeno ET
    Proc West Pharmacol Soc; 1966; 9():62. PubMed ID: 6006186
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative activity of psychotoxic drugs on the avian optic lobe.
    Scholes NW; Gutnick MJ
    Eur J Pharmacol; 1970; 12(3):289-96. PubMed ID: 5531373
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance and cross-tolerance among psychotomimetic drugs.
    Appel JB; Freedman DX
    Psychopharmacologia; 1968 Sep; 13(3):267-74. PubMed ID: 5679628
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of isolation-induced attack behavior of mice by drugs.
    Uyeno ET
    J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
    [No Abstract]   [Full Text] [Related]  

  • 13. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelics and mental health: a population study.
    Krebs TS; Johansen PØ
    PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.
    Vaupel DB; Nozaki M; Martin WR; Bright LD; Morton EC
    Life Sci; 1979 Jun; 24(26):2427-31. PubMed ID: 481115
    [No Abstract]   [Full Text] [Related]  

  • 16. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
    Cameron OG; Appel JB
    Psychopharmacologia; 1973; 33(2):117-34. PubMed ID: 4272898
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of excitatory and tranquilizing drugs on visual perception.
    Hill RM; Fischer R; Warshay D
    Am J Optom Arch Am Acad Optom; 1968 Jul; 45(7):454-7. PubMed ID: 5243948
    [No Abstract]   [Full Text] [Related]  

  • 18. [Halluciogenic substances and sleep mechanisms].
    Rougeul A; Verdeaux J
    Rev Can Biol; 1972; 31():Suppl:49-58. PubMed ID: 4538208
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.
    Menon MK; Clark WG; Masuoka DT
    Psychopharmacology (Berl); 1977 May; 52(3):291-7. PubMed ID: 406633
    [No Abstract]   [Full Text] [Related]  

  • 20. Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.
    HOLLISTER LE; HARTMAN AM
    Compr Psychiatry; 1962 Aug; 3():235-42. PubMed ID: 13908449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.